What we do Tarsons Products Ltd is an Indian labware company designing, manufacturing, and marketing consumables, reusables, and benchtop equipment used in research, pharma, diagnostics, and hospitals. |
Founded in 1,983 |
Market share Among the top 3 players in the fragmented Indian labware market with a robust pan-India distribution and growing global presence. |
Problem solved Provides high-quality, cost-effective labware solutions that support scientific discovery and healthcare improvement by replacing imports. |
Top clients or who we serve Serves research institutes, academia, pharma companies, Contract Research Organizations, diagnostic labs, and hospitals; mainly B2B segment. |
Key management Chairman & Managing Director Mr. Sanjive Sehgal, Whole-Time Director Mr. Aryan Sehgal, CFO Mr. Santosh Kumar Agarwal. |
Our journey and innovations Launched pipette tips (1984), robotic clean room for molecular biology consumables (2002), expanded to PCR & cryogenic vials, acquired Nerbe in Germany (2023). |
Where we operate Operates primarily in India with expanding global reach including Germany and exports to over 40 countries worldwide. |
Top products or what we offer Offers lab consumables like pipette tips, centrifuge tubes, cryo vials, PCR consumables, reusables, and benchtop instruments under several product categories. |
Top brands Key product names include Maxipense, Spinwin, and Cryochill; known for quality, reliability, and wide acceptance in life sciences. |
Raw materials needed Medical grade DMF-registered plastic resins are primary raw materials with specifications for purity and performance. |
Raw materials supplier Supplied by approved vendors; specific supplier names not disclosed publicly. |
Recurring vs cyclical contribution Revenue is largely recurring from continuous lab consumables demand with a stable customer base. |
Our industry position Strong domestic leadership with growing international footprint; holds significant market share in Indian labware sector. |
Financial highlights FY25 consolidated revenue Rs. 392.41 Cr; net profit Rs. 29.77 Cr; steady revenue growth with expanding margins and investments in capacity. |
Geographical revenue split India contributes approximately 80%, Germany and other overseas markets nearly 20% combined to total revenues. |
Order book No specific order book data disclosed; focus on long-term customer contracts and expanding export partnerships. |
Whats driving growth Capacity expansions, new product launches, automation investments, and international acquisitions drive growth. |
Our future plans Operationalize new Panchla and Amta facilities, expand cell culture and radiation sterilization products, grow export markets. |
Our green promise Strong commitment to employee safety, no environmental litigations in past 5 years, CSR initiatives supporting community health. |
Our people and values Employs 900+ people; promotes training, safety, diversity, zero tolerance for workplace harassment, and employee welfare. |
Key challenges ahead Managing costs during capacity expansions, competitive pressures, and integration of international acquisitions. |
Interesting facts Pioneered India’s first fully robotic clean room for molecular biology consumables manufacturing in 2002. |
Risks and strategy Mitigates operational risks via advanced automation, diversification of markets, and strong corporate governance. |
